COVID-19 vaccination and new onset glomerular disease: Results from the IRocGN2 International Registry

Authors

• Meryl Waldman, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
• Ninet Sinaii, Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland.
• Edgar V. Lerma, Advocate Aurora Health
• Anila Abraham Kurien, Center for Renal and Urological Pathology, Chennai, Tamil Nadu, India.
• Kenar D. Jhaveri, Division of Kidney Diseases and Hypertension, Glomerular Center at Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, New York.
• Nupur N. Uppal, Division of Kidney Diseases and Hypertension, Glomerular Center at Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, New York.
• Rimda Wanchoo, Division of Kidney Diseases and Hypertension, Glomerular Center at Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, New York.
• Rupali Avasare, Division of Nephrology and Hypertension, Department of Medicine, Oregon Health & Science University, Portland, Oregon.
• Jonathan E. Zuckerman, Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California.
• Adrian Liew, The Kidney and Transplant Practice, Mount Elizabeth Novena Hospital, Singapore.
• Alexander J. Gallan, Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.
• Ashraf El-Meanawy, Division of Nephrology, Medical College of Wisconsin, Milwaukee, Wisconsin.
• Yoram Yagil, Department of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel.
• Larissa Lebedev, Department of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel.
• Krishoban Baskaran, Department of Nephrology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
• Eswari Vilayur, Department of Nephrology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
• Adrienne Cohen, Department of Nephrology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
• Nethmi Weerasinghe, Department of Nephrology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
• Ioannis Petrakis, Department of Nephrology, General University Hospital of Heraklion, Crete, Greece.
• Kostas Stylianou, Department of Nephrology, University of Crete, Greece.
• Hariklia Gakiopoulou, Department of Pathology, Hellenic and Kapodistrian University of Athens, Greece.
• Alexander J. Hamilton, Exeter Kidney Unit, Royal Devon University Healthcare NHS Foundation Trust, United Kingdom.
• Naomi Edney, Exeter Kidney Unit, Royal Devon University Healthcare NHS Foundation Trust, United Kingdom.
• Rachel Millner, Department of Pediatrics, Pediatric Nephrology, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
• Smaragdi Marinaki, Clinic of Nephrology and Renal Transplantation, NKUA, Medical School, Laiko General Hospital, Athens, Greece.
• Joshua L. Rein, Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
• et al

Recommended Citation

Waldman M, Sinaii N, Lerma EV, et al. COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry. Kidney360. 2023;4(3):349-362. doi:10.34067/KID.0006832022

Affiliations

Advocate Christ Medical Center

Document Type

Article

PubMed ID

36996301